{{Rsnum
|rsid=6138892
|Chromosome=20
|position=2774842
|Orientation=plus
|GMAF=0.1511
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 38.7 | 61.3
| HCB | 2.9 | 28.5 | 68.6
| JPT | 0.9 | 23.9 | 75.2
| YRI | 0.7 | 24.1 | 75.2
| ASW | 1.8 | 21.1 | 77.2
| CHB | 2.9 | 28.5 | 68.6
| CHD | 0.0 | 34.6 | 65.4
| GIH | 0.0 | 20.8 | 79.2
| LWK | 0.9 | 21.8 | 77.3
| MEX | 1.8 | 29.8 | 68.4
| MKK | 0.6 | 22.7 | 76.6
| TSI | 0.0 | 26.5 | 73.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=3E-7
|OR=10.9300
|ORtxt=None
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}